Italian Medicines Agency Agenzia Italiana del Farmaco

Technical and advisory committees

Technical and advisory committees

AIFA’s authority and scientific autonomy is supported by two scientific technical committees, comprising experts with proven and documented experience in the sector.

The Scientific Technical advisory Committee (CTS) and the Price and Reimbursement Committee (CPR) are appointed by decree of the Minister of Health, and are each made up of ten members, three of whom are designated by the Minister of Health, one of whom acts as president, one member is appointed by the Minister of economy and finance and four by the Permanent Conference for relations between the State, the Regions and the Autonomous Provinces of Trento and Bolzano. The Director General of the Agency and the President of the National Institute of Health are statutory members. Non-statutory members remain in office for three years, renewable consecutively only once. Non-statutory members of the Scientific Technical Committee are selected within experts with proven and documented scientific technical competence, of at least five years in the field of pharmaceutical assessment. Non-statutory members of the Price and Reimbursement Committee are chosen from among people with proven expertise, with at least five years’ experience in the sector of drug pricing methodology, health economics, pharmacoeconomics and health organisation, as well as within health law experts.

Please note that the assessment procedures (performed by the competent AIFA Committee) of the public declarations of interest (DoI) issued by the aforementioned committee members are currently ongoing.

Scientific technical committee (CTS)

This committee deals with the activities related to Marketing Authorisation applications of new medicines - through both national and community procedures – by determining the cost-effectiveness ratio. It evaluates and provides an advisory opinion on the classification of medicinal products for reimbursement purposes.

CTS members

Statutory members:

  • Director General of the Italian Medicines Agency
  • Delegate of the President of the Italian National Institute of Health (Dr Mauro Biffoni)

Appointed members:

  • Dr Patrizia Popoli – acting as Chairperson
  • Dr Antonio Addis
  • Prof. Carlo Caltagirone
  • Prof. Giovambattista De Sarro
  • Dr Ida Fortino
  • Dr Armando Genazzani
  • Dr Anna Maria Marata
  • Dr Paolo Schincariol

 

Price and Reimbursement Committee (CPR)

This committee performs negotiations for the reimbursement of medicinal products; its resolutions are subsequently submitted to the CTS’ assessment to issue the final opinion.

CPR members

Statutory members:

  • Director General of the Italian Medicines Agency
  • Delegate of the President of the Italian National Institute of Health (Dr Mauro Biffoni)

Appointed members:

  • Dr Giovanna Scroccaro – acting as Chairperson
  • Dr Roberto Banfi
  • Dr Annalisa Campomori
  • Dr Beniamino Colagrosso
  • Prof. Amelia Filippelli 
  • Dr Loredano Giorni 
  • Prof. Vincenzo Stefano Rebba 
  • Dr Paolo Stella

Nested Applications

Last tweets

Go to Twitter profile

Multimedia

ABC della Ricerca Clinica - Perché la randomizzazione è essenziale?

Go to YouTube channel

go to beginning of content